Table 2.
Analysis of confounding factors for tHcy and CRP.
| tHcy (μmol/L) | CRP (mg/L) | |
|---|---|---|
| ApoE ε4 carrier status | Carrier: 13.43 (12.68, 14.22) | Carrier: 1.08 (0.80, 1.44) |
| Noncarrier: 13.68 (12.62, 14.83) | Noncarrier: 1.86 (1.40, 2.47) | |
| P = 0.71 | P = 0.01 | |
|
| ||
| Gender | Males: 14.32 (13.52, 15.21) | Males: 1.15 (0.84, 1.56) |
| Females: 12.68 (11.78, 13.68) | Females: 1.66 (1.25, 2.20) | |
| P = 0.01 | P = 0.08 | |
|
| ||
| Statin use status | Statin—yes: 13.15 (12.05, 14.32) | Statin—yes: 1.57 (1.09, 2.28) |
| Statin—no: 13.80 (13.06, 14.59) | Statin—no: 1.24 (0.97, 1.59) | |
| P = 0.32 | P = 0.28 | |
Geometric mean (95% confidence interval).
P: P value.